COVID-19 Vaccines: June 2021 Update from the FDA
ACPE Activity Number: 0204-0000-21-045-H06-P, 0204-0000-21-045-H06-T
Release Date: June 2, 2021
Expiration Date: June 2, 2024
Activity Type: Knowledge-based
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Free
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Join us as we welcome back Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research (CBER) at the FDA. His leadership has led to effective and transparent decisions about COVID-19 vaccine candidates. During the webinar, he will provide insight into the updates such as: use in pediatrics/adolescents, vaccine durability, and ongoing safety and efficacy monitoring. Stay informed on the COVID-19 vaccine clinical trials and the vaccine approval process so that you can make informed decisions as the vaccine landscape continues to evolve.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, pharmacy department leadership, organizational leaders including other pharmacy associations.
1. Describe current state of vaccine candidates against SARS-CoV-2 in pediatrics and adolescents
2. Summarize research efforts for COVID-19 vaccines post emergency use authorization
3. Discuss evaluation approaches for the COVID-19 vaccines against the SARS-CoV-2 variants
4. Describe ongoing safety and efficacy monitoring for vaccines
Schedule of Activities
- Introduction and Announcements
- Questions, Answers, and Discussion
- Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER), FDA
- Tom Kraus, JD, Vice President of Government Relations, ASHP
In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.
- All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.
Methods and CE Requirements
This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.